President and COO of Ligand Pharmaceuticals Inc (30-Year Financial, Insider Trades) Matthew W Foehr (insider trades) sold 7,303 shares of LGND on 08/24/2020 at an average price of $112.86 a share. The total sale was $824,217.
Ligand Pharmaceuticals Inc is a biopharmaceutical company. Its business model is based upon the concept of acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand Pharmaceuticals Inc has a market cap of $1.74 billion; its shares were traded at around $108.40 with and P/S ratio of 14.83. Ligand Pharmaceuticals Inc had annual average EBITDA growth of 105.40% over the past five years. GuruFocus has detected 3 severe warning signs with Ligand Pharmaceuticals Inc. .
Directors and Officers Recent Trades:
- President and COO Matthew W Foehr sold 7,303 shares of LGND stock on 08/24/2020 at the average price of $112.86. The price of the stock has decreased by 3.95% since.
For the complete insider trading history of LGND, click here.